A Prospective, Randomized, Double-Blind, Cross-over Study of Lidocaine Patch 1.8% in Patients With Moderate to Severe Pain From Carpal Tunnel Syndrome
Latest Information Update: 13 Jun 2023
At a glance
- Drugs Lidocaine (Primary)
- Indications Neuropathic pain
- Focus Therapeutic Use
Most Recent Events
- 07 Jun 2023 Status changed from not yet recruiting to completed.
- 03 Feb 2020 New trial record